Method | Â | References |
---|---|---|
Ultracentrifugation | 120,000 g, 18 h, 4 °C, SW32 Ti rotor (Beckman Coulter, Brea, CA, USA) | [66] |
Ultrafiltration | Amicon ultra-15 centrifugal filters (UFC910024, 100 K filters and benchtop Merk Millipore Ltd., Tullagreen, Carrigtwohill, Co. Cork, Ireland), 3,000 g, 55 min, 4 °C | [62] |
Tangential flow filtration (TFF) | hollow fiber-modified polyethersulfone (mPES) membrane filter column (area 1,600 cm2, 500Â kDa molecular weight cut off) operated on a KR2i TFF System (Repligen, USA) | [67] |
Commercially available exosome-depleted serum or medium | MesenCultâ„¢-ACF Plus (STEMCELL Technologies, China); | [68] |
Exo-FBSâ„¢ (System Biosciences, Mountain View, CA, USA); | [69] | |
OxiumTMEXO (patent No. PCT/CL2019/100175); | [70] | |
RoosterCollect EV Proâ„¢ (RoosterBio Inc., Frederick, MD, USA) | [71] | |
Fibrinogen and fibrin depletion | Hydrogel formation was facilitated for 4 h at room temperature (RT) followed by overnight incubation at 4 °C. The resulting coagulated medium was heated to 37 °C for 1 h to enable a complete fibrin clotting. Afterward, a collapse was induced by vigorous shaking followed by centrifugation at 3000 g for 10 min at RT. Finally, the clear medium supernatant was filtered through a 0.22 µm filter (Merck Millipore, Billerica, MA, USA) | [72] |